GlioCART
Restoring Immune Control in Glioblastoma
Switzerland · $250K raised
- Business Model
- B2B
- Website
- gliocart.ch
- Total Funding
- $250K
- Last Round
- $187K SeedNov 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
GlioCART develops dual-action CAR-T therapy for glioblastoma, addressing immunosuppression and antigen escape by targeting tumor cells and reprogramming tumor-supporting myeloid cells into active immune effectors. Glioblastoma remains one of the most aggressive cancers, with median survival of only 15 months and no therapeutic progress in over two decades. The company aims to extend CAR-T therapy beyond hematologic malignancies into solid tumors, starting with glioblastoma and expanding into other myeloid-driven cancers, holding exclusive worldwide license rights from the University of Basel.
Summary
GlioCART is a Biotech company based in Switzerland. It has raised $250K in total across 2 rounds, most recently a $187K Seed round in Nov 2025. Investors include Venture Kick.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 2 events
Funding: Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gliocart"><img src="https://indexed.vc/api/badge/company/gliocart" alt="GlioCART on Indexed.vc" width="260" height="76" /></a>